RxDoctor Payments Data

Lindsey Graff, NP

Nurse Practitioner · Stanley, WINPI 1467871525

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $8,955 of the $14,717 with a category attached, or 60.8%. Organogenesis Inc. accounts for 98.3% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $6,912 and has fallen 66.1% since, to $2,346 in 2025. Among nurse practitioner clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$14,717in general payments, 2019–2025

Across 41 payments — averaging $358.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$14K
  • UCB, Inc.$54
  • Ferring Pharmaceuticals Inc.$50
  • Smith+Nephew$41
  • Pacira Pharmaceuticals Incorporated$36
  • Coloplast$34
  • plus $35 from 2 others

What the payments were for

  • Consulting fees$3,87526%
  • Speaking & faculty fees$8,95561%
  • Travel & lodging$9727%
  • Food & beverage$9156%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,717 in reported general payments places this provider in the 95th percentile of 3,478 nurse practitioner providers in Wisconsin.

See all nurse practitioner providers in Wisconsin

Medicare billing

Part B allowed, 2024
$12,232
Medicare patients
92
Services billed
251

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl21$112
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$88
Tramadol Hcl28$80
Meloxicam12$69

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Stanley

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →